Home » Topics » Regulatory

Regulatory
RSS

FDA approves Novartis' Tasigna for newly diagnosed Ph+ CML

June 21, 2010

FDA approves Jevtana for metastatic hormone-refractory prostate cancer

June 18, 2010

Prolia obtains marketing authorization in E.U.

May 31, 2010

FDA approves Vimovo delayed-release tablets for arthritis patients

May 3, 2010

Dendreon receives FDA approval for Provenge for castrate-resistant prostate cancer

April 30, 2010

Takeda obtains five NDA approvals in Japan

April 20, 2010

Diquas ophthalmic solution approved in Japan for dry eye treatment

April 19, 2010

EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer

March 30, 2010

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

FDA approves Somaxon's Silenor for treatment of insomnia

March 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...